CSF's play an important role in the survival, growth, and differentiation of hematopoietic progenitor cells both in vitro and in vivo, the differentiation and proliferation from progenitor cells to mature granulocytes being dependent on its presence (Metcalf, 1984) . CSF's have also been implicated in the tumour-induced leukocytosis that, rarely, accompanies various malignant solid tumours in the absence of infection. This has been suggested in several case reports in which a clonogenic bioassay was used (Asano et al., 1977; Sato et al., 1979) . However, with bioassay employed in those studies, the investigators were unable to determine which CSF's were essential for this leukocytosis. The precise in vivo role of G-CSF in tumour-induced leukocytosis is still unknown, although autonomous production of CSF's by human neoplasms has been suggested (Lee et al., 1989) . In this study, we examined 155 human tumour xenografts in athymic animals as an in vivo experimental model of tumour-induced leukocytosis. We isolated 17 tumour xenografts which induced leukocytosis in the host animals. To clarify the in vivo mechanisms underlying tumour-induced leukocytosis, we examined G-CSF gene expression and G-CSF production in the human tumour xenografts. Materials We used an in vitro G-CSF-producing cell line, CHU-2 (generously provided by Dr M. Ono, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan). This cell line was cultured in RPMI-1640 supplemented with 10% foetal bovine serum in 5% CO2 at 37'C.
White blood cell (WBC) count
The blood volume of nude mice is too small to precisely examine peripheral blood WBC counts. We usually obtain 0.5 to 1 ml/animal of peripheral blood from nude mice (25 g), whereas nude rats provide 4-to 8-ml samples were animal (100 g). In addition, levels of peripheral blood WBC counts are relatively more stable in nude rats than in nude mice. In this study, we transplanted human tumour xenografts into nude rats to estimate peripheral blood WBC counts (F344, Clea Japan Inc., Tokyo, Japan). Peripheral blood samples were obtained from the tail veins of nude rats when the xenografts grew to more than 10 g within 2 months after transplantation.
Northern blot analysis
We examined the expression of G-CSF transcripts in the xenografts by Northern blot analysis (Maniatis et al., 1989) .
Fifteen ILg of the total RNA samples was run on an agarose gel and blotted onto a membrane (Gene Screen Plus, New England Nuclear). A human G-CSF cDNA NcoI/EcoRI fragment was prepared from a pVR2 plasmid Nagata et al., 1986) . The blots were hybridised with a G-CSF 32P-labelled cDNA probe under the conditions recommended by the manufacturer. We evaluated the G-CSF-specific transcript (1.8 kb) by autoradiography and we examined housekeeping gene expression by re-hybridisation of the blots with a P-actin cDNA probe to qualify RNA.
Serum G-CSF levels
We examined sample sera (50p1) withdrawn from the nude rats within 2 months after the transplantation of the human tumour xenografts. Serum G-CSF protein levels were examined by enzyme immunoassay (EIA), using antirecombinant human G-CSF polyclonal antibody, as described previously (Motojima et al., 1989) .
We examined serum G-CSF biological activity by determining [3H]-thymidine uptake in a G-CSF-dependent murine leukaemic cell line, NFS-60 (Shirafuji et al., 1989 Immunohistochemical detection of G-CSF An indirect immunostaining method was used, employing anti-recombinant human G-CSF monoclonal antibody (Shimamura et al., 1990) . Sections were incubated with anti G-CSF antibody and with a peroxidase-labelled rabbit antimouse immunoglobulin antibody. The visualising reaction was carried out in 20% 3,3'-diaminobenzidine-4HCl, 0.005% H202, and 1 M Tris-Cl buffer (pH 7.6).
Results

Peripheral blood WBC count
The peripheral blood WBC count had a mean value of 8,756 gil-1 (s.d. 3,068) in the normal nude rats. The differential peripheral WBC counts showed 45% neutrophils, 46% lymphocytes, and 7% monocytes in the normal nude rats. Seventeen (3 thyroid, 5 lung, 3 oral cavity, 1 gastric, 1 renal, 1 pancreatic, 1 gallbladder, 1 liver cell carcinoma and 1 brain tumour) of 155 (11%) human tumour xenografts showed remarkable neutrophilic-dominant leukocytosis, of more than 14,892 gil-', in nude rats (mean + 2 s.d., Table I ). Differential WBC counts revealed that neutrophils (59%-94%) primarily accounted for the leukocytosis in animals with tumour xenografts. Patients with primary neoplasms showed various levels of neutrophilic-dominant leukocytosis (11, 600 gil') without any bacterial infection.
Expression of G-CSF gene Northern blot analyses showed a G-CSF transcript (1.8-kb) in ten of the 17 tumour xenografts (59%) that induced severe leukocytosis in the host nude rats ( Figure 1 and Table II) . These ten tumour xenografts showed heterogeneous levels of G-CSF gene expression. The G-CSF transcripts showed no apparent size variation. Northern analysis was also performed in 50 of the 138 tumour xenografts that had no leukocytosis; no G-CSF transcripts were noted in any of these 50 tumour xenografts. These results suggested that autonomous G-CSF production in some tumour xenografts induced leukocytosis in the host animals.
Serum G-SCF levels We evaluated G-CSF protein levels in the serum of nude rats by EIA with anti G-CSF polyclonal antibodies. EIA performed in 30 of the 138 sera from nude rats that had no leukocytosis, and also in 10 normal nude rats, demonstrated no detectable levels of G-CSF (< 60 pg ml-') in any of these sera. The ten tumour xenograft lines expressing the G-CSF transcripts showed significant increases in serum G-CSF levels (179-37,218 pg ml-) (Table II) . The tumour xenograft lines that did not appear to express G-CSF transcripts showed no increase in serum G-CSF levels.
G-CSF biological activity
We confirmed the biological activity of the G-CSF by NFS-60 cell proliferation assay. The ten human tumour xenografts that expressed G-CSF transcripts showed significant increases in G-CSF biological activity (1,259-9,074 pg ml ') ( Table  II) . The bioassay demonstrated no significant increase in G-CSF biological activity (<195pgml-') in the nude rats with human tumour xenografts that did not exhibit G-CSF gene expression.
Immunohistochemical detection of G-CSF production
We have detected G-CSF production in the tumour xenografts at the cellular level by immunohistochemical analysis with anti G-CSF monoclonal antibody. This immunohistochemical method demonstrated G-CSF positive cells in three out of the ten xenografts that expressed the G-CSF transcript (Table II) , the incidence of G-CSF-positive tumour cells in these three xeonografts being extremely low (Figure 2 ). The tumour xenografts without G-CSF transcripts showed no G-CSF-positive cells. This immunohistochemical analysis was also performed in 30 of the 138 tumour xenografts that had no leukocytosis; no G-CSF-positive cells were found in the tumour xenografts. Fibbe et al., 1989) . Cytokines, including interleukin-I and tumour necrosis factor, modulate G-CSF production by mesothelial cells (Demetri et at., 1989 It has been shown that G-CSF stimulated the clonogenic -~~.~growth of some nonw-hematopoietic cell lines in vitro (Berdel et at., 1989; Avalos et at., 1990 
